Costs of Treating Onasemnogene Abeparvovec‐Xioi‐Induced Liver Injury

Costs of Treating Onasemnogene Abeparvovec‐Xioi‐Induced Liver Injury

ABSTRACT Aims were to reveal types of onasemnogene abeparvovec‐xioi (OA)‐induced liver injury, their treatment patterns, utilization of healthcare, and treatment costs. This study employed secondary research to analyze OA‐induced liver injury using data from the EudraVigilance database, published ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrej Belančić, Branislava Raičević, Ivana Stević, Dinko Vitezić, Slobodan M. Janković
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Pharmacology Research & Perspectives
Subjects:
drug safety
gene therapy
liver injury
onasemnogene abeparvovec‐xioi
pharmacoeconomics
spinal muscular atrophy
Online Access:https://doi.org/10.1002/prp2.70134
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items